<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chapman KA</submitter><funding>National Institute of Neurological Disorders and Stroke</funding><funding>NIMH NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>National Institute of Mental Health</funding><funding>National Institutes of Health</funding><funding>University of Arizona</funding><pagination>2381-2401</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12440709</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>112(10)</volume><pubmed_abstract>Transmembrane protein 184B (TMEM184B) is an endosomal 7-pass transmembrane protein with evolutionarily conserved roles in synaptic structure and axon degeneration. We report six pediatric cases who have de novo heterozygous variants in TMEM184B; five individuals harbor a rare missense variant, and one individual has an mRNA splice site change. This cohort is unified by overlapping neurodevelopmental deficits including developmental delay, corpus callosum hypoplasia, seizures, and/or microcephaly. TMEM184B is predicted to contain a pore domain wherein four of five human disease-associated missense variants cluster. Structural modeling suggests that all missense variants alter TMEM184B protein stability. To understand the contribution of TMEM184B to neural development in vivo, we knocked dow</pubmed_abstract><journal>American journal of human genetics</journal><pubmed_title>Pathogenic variants in TMEM184B cause a neurodevelopmental syndrome associated with alteration of metabolic signaling.</pubmed_title><pmcid>PMC12440709</pmcid><funding_grant_id>R01 MH106826</funding_grant_id><funding_grant_id>R01 NS105680</funding_grant_id><pubmed_authors>Muss C</pubmed_authors><pubmed_authors>Powell AT</pubmed_authors><pubmed_authors>Keren B</pubmed_authors><pubmed_authors>Sofocleous C</pubmed_authors><pubmed_authors>Chapman KA</pubmed_authors><pubmed_authors>Pond KW</pubmed_authors><pubmed_authors>Fryssira H</pubmed_authors><pubmed_authors>Correia SP</pubmed_authors><pubmed_authors>Accogli A</pubmed_authors><pubmed_authors>Berger SI</pubmed_authors><pubmed_authors>Davis EE</pubmed_authors><pubmed_authors>Kellaris G</pubmed_authors><pubmed_authors>Traeger-Synodinos J</pubmed_authors><pubmed_authors>Stodberg T</pubmed_authors><pubmed_authors>Tsoutsou E</pubmed_authors><pubmed_authors>Sciruicchio V</pubmed_authors><pubmed_authors>Kodiparthi SV</pubmed_authors><pubmed_authors>Marinakis NM</pubmed_authors><pubmed_authors>Salpietro V</pubmed_authors><pubmed_authors>Striano P</pubmed_authors><pubmed_authors>Heron D</pubmed_authors><pubmed_authors>Sirimulla S</pubmed_authors><pubmed_authors>Bhattacharya MRC</pubmed_authors><pubmed_authors>White HG</pubmed_authors><pubmed_authors>Ullah F</pubmed_authors><pubmed_authors>Yahiku ZA</pubmed_authors><pubmed_authors>Khan S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Pathogenic variants in TMEM184B cause a neurodevelopmental syndrome associated with alteration of metabolic signaling.</name><description>Transmembrane protein 184B (TMEM184B) is an endosomal 7-pass transmembrane protein with evolutionarily conserved roles in synaptic structure and axon degeneration. We report six pediatric cases who have de novo heterozygous variants in TMEM184B; five individuals harbor a rare missense variant, and one individual has an mRNA splice site change. This cohort is unified by overlapping neurodevelopmental deficits including developmental delay, corpus callosum hypoplasia, seizures, and/or microcephaly. TMEM184B is predicted to contain a pore domain wherein four of five human disease-associated missense variants cluster. Structural modeling suggests that all missense variants alter TMEM184B protein stability. To understand the contribution of TMEM184B to neural development in vivo, we knocked dow</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-06-04T11:00:33.08Z</modification><creation>2026-05-08T03:10:51.717Z</creation></dates><accession>S-EPMC12440709</accession><cross_references><pubmed>40885185</pubmed><doi>10.1016/j.ajhg.2025.08.004</doi></cross_references></HashMap>